皇家华人

header-logo
GettyImages-609179959-hero
headshot

James P. Thomas, MD, PhD

Professor

view physician profile

Locations

  • Froedtert Hospital
  • Cancer Center - Froedtert Hospital

Specialties

  • Hematology
  • Medical Oncology

Languages

  • English

Cancer Center - Froedtert Hospital

Established Patient Appointments

New & Established Patients Call

Education

  • MD - Doctor of Medicine
  • PhD

Biography

James Thomas, MD, PhD, joined the faculty at the 皇家华人 in the Division of Hematology and Oncology in September of 2010. Dr. Thomas received his PhD in Biochemistry and his MD from the 皇家华人. He completed his residency training in internal medicine at the 皇家华人 and subsequently completed a fellowship in Medical Oncology at the University of Wisconsin. Dr. Thomas joined the faculty at the University of Wisconsin and was the Disease Leader for Gastrointestinal Cancers. Dr. Thomas served as the Medical Director of the Clinical Trials Office of the Ohio State Comprehensive Cancer Center and was on the NCCN Panel for Colorectal Cancers. He is the Chair of the American Association of Cancer Institutes Clinical Research Group. Dr. Thomas has published over 70 peer reviewed articles.

Research Interests

His research interests are in oncology drug development and in the treatment of gastrointestinal cancers. Dr. Thomas has a long standing research effort in the role of reactive oxygen species in cancer development and treatment.

Publications

  • (Thomas JP, Geiger PG.) Cancer Res. Thomas JP, Geiger PG. Abstract 4443: PB-42: Design and characterization of a glutathione pro-drug selectively delivered to normal tissue and not tumor tissue. Cancer Res. August 1, 2015 75; 4443. 08/01/2015

  • (Wang F, Qi XM, Wertz R, Mortensen M, Hagen C, Evans J, Sheinin Y, James M, Liu P, Tsai S, Thomas J, Mackinnon A, Dwinell M, Myers CR, Bartrons Bach R, Fu L, Chen G.) Cancer Res. 2020 Aug 15;80(16):3251-3264 PMID: 32580961 PMCID: PMC9358694 SCOPUS ID: 2-s2.0-85089787021 06/26/2020

  • (Stein A, Strong E, Clark Gamblin T, Clarke C, Tsai S, Thomas J, George B, Mogal H.) Ann Surg Oncol. 2020 Jan;27(1):85-97 PMID: 31583543 SCOPUS ID: 2-s2.0-85074461946 10/05/2019

  • (Porter M, Ramaswamy B, Beisler K, Neki P, Single N, Thomas J, Hofacker J, Caligiuri M, Carson WE 3rd.) Ann Surg Oncol. 2016 Jul;23(7):2146-52 PMID: 26790668 01/23/2016

  • (Yin N, Qi X, Tsai S, Lu Y, Basir Z, Oshima K, Thomas JP, Myers CR, Stoner G, Chen G.) Oncogene. 2016 Feb 25;35(8):1039-48 PMID: 25961922 SCOPUS ID: 2-s2.0-84959509513 05/12/2015

  • (Miura JT, Johnston FM, Tsai S, George B, Thomas J, Eastwood D, Banerjee A, Christians KK, Turaga KK, Pawlik TM, Clark Gamblin T.) Ann Surg Oncol. 2015 Oct;22(11):3716-23 PMID: 25777092 SCOPUS ID: 2-s2.0-84941418828 03/18/2015

  • (Jayakrishnan TT, Nadeem H, Groeschl RT, George B, Thomas JP, Ritch PS, Christians KK, Tsai S, Evans DB, Pappas SG, Gamblin TC, Turaga KK.) HPB (Oxford). 2015 Feb;17(2):131-9 PMID: 25123702 PMCID: PMC4299387 SCOPUS ID: 2-s2.0-84920841239 08/16/2014

  • (Zacharias AJ, Jayakrishnan TT, Rajeev R, Rilling WS, Thomas JP, George B, Johnston FM, Gamblin TC, Turaga KK.) PLoS One. 2015;10(10):e0139940 PMID: 26448327 PMCID: PMC4598149 SCOPUS ID: 2-s2.0-84948706797 10/09/2015

  • (Miura JT, Xiu J, Thomas J, George B, Carron BR, Tsai S, Johnston FM, Turaga KK, Gamblin TC.) Cancer Biol Ther. 2015;16(5):764-9 PMID: 25778705 PMCID: PMC4622996 SCOPUS ID: 2-s2.0-84943767513 03/18/2015

  • (Miura JT, Johnston FM, Thomas J, George B, Eastwood D, Tsai S, Christians KK, Turaga KK, Gamblin TC.) J Surg Oncol. 2014 Sep;110(3):302-6 PMID: 24844210 SCOPUS ID: 2-s2.0-84905367494 05/23/2014

  • (Hwang M, Jayakrishnan TT, Green DE, George B, Thomas JP, Groeschl RT, Erickson B, Pappas SG, Gamblin TC, Turaga KK.) Eur J Cancer. 2014 Jul;50(10):1747-1757 PMID: 24767470 SCOPUS ID: 2-s2.0-84901752316 04/29/2014

  • (Jordan Kharofa, Tracy R. Kelly, Paul S. Ritch, Ben George, Lauren Allison Wiebe, James P. Thomas, Kathleen K. Christians, Douglas B. Evans, Beth Erickson .) Journal of Clinical Oncology . 10.1200/jco.2012.30.15_suppl.e1461 Journal of Clinical Oncology 30, no. 15_suppl -published online before print 01/09/2018

Publications of from the

© 2024 皇家华人.  All rights reserved.  | Terms and Privacy 

Non-Discrimination Statement
The 皇家华人 (MCW) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, or military status. Employees, students, applicants or other members of the MCW community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic. MCW’s policy as well as federal and state laws and regulations prohibit unlawful discrimination and harassment.